Indutrade acquires the Irish MedTech company MeHow

Report this content

Indutrade has signed an agreement to acquire all shares in the Irish company MeHow Medical Ireland Ltd., www.mehow.ie, with annual sales of approximately EUR 14 million (SEK 160 million).

MeHow is a leading manufacturer and engineering partner of injection moulded components for the global medical device industry. The company offers a wide range of sub-assemblies based on moulded components, dispenser coils for cardiovascular products such as guidewires and catheters, and toolmaking to leading international OEM customers. MeHow has extensive production capabilities, all in controlled cleanroom environment with a high degree of automation.

MeHow was founded in 2007, has 56 employees and is located in Bray Co. Wicklow, Ireland. The company has significant engineering competence and material knowledge as well as strong market positions in fast growing niche segments, which provide good opportunities for continued sustainable, profitable growth.

The closing takes place today and MeHow will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's third in 2024 and is expected to have a marginally positive impact on Indutrade's earnings per share.  

Stockholm, 31 January 2024

INDUTRADE AB (publ)

For further information, please contact:
Bo Annvik, President and CEO
Phone +46 8 703 03 00

About Indutrade
Indutrade is an international technology and industrial business group that today consists of approximately 200 companies in some 30 countries, mainly in Europe. In a decentralised way, we aim to provide sustainable profitable growth by developing and acquiring successful companies managed by passionate entrepreneurs. Our companies develop, manufacture, and sell components, systems and services with significant technical content in selected niches. Our value-based culture, where people make the difference, has been the foundation of our success since the start in 1978. Indutrade's net sales totalled SEK 27 billion in 2022, and the share is listed on Nasdaq Stockholm in Sweden.